Sweet Scents to Sweet Dreams (SSS)

April 14, 2026 updated by: Paula Witt-Enderby, Duquesne University

Sweet Scents to Sweet Dreams: Use of Herbal Pillows to Facilitate Sleep and Improve Quality of Life

The purpose of this study is to determine the effect of herbal pillows on sleep and quality of life in a healthy population using actigraphy, validated questionnaires and daily diary logs. The goal of this study is to improve sleep and quality of life using herbal and Ayurveda/holistic-based botanical pillows.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15282
        • Duquesne University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • You must be at least 18 years of age.
  • You must be willing to adhere to a sleep hygiene protocol (e.g., 10pm-midnight-6-8am) for 2 weeks without interruption in the comfort of your home.
  • You must be willing to wear a watch that monitors your sleep and light as well as a sleep mask for two consecutive weeks.
  • During the testing period, you must be willing to refrain from alcohol and anything that can affect mood and sleep.
  • You must allow for the placement of an herbal pillow next to your head while sleeping for one week during testing.
  • You must be willing to fill out short sleep logs during the 2 weeks of testing.
  • You must also be willing to come to the study location on 3 occasions over a 2 week period.

Exclusion Criteria:

  • Males or females with any condition that prevents adequate inhalation of botanical pillows [e.g., Chronic Obstructive Pulmonary Disease (COPD), use of a Continuous Positive Airway Pressure (CPAP), deviated septum, etc].
  • Males or females on mood altering substances prescription (e.g., anti-depressants, anxiolytics, Ritalin, Adderall, anti-convulsants; opioids, etc), non-prescription/over-the-counter (OTC) drugs/herbal/natural products [(e.g., tetrahydrocannabinol (THC)-containing compounds, melatonin, St. John's Wort, lavender capsules, essential oils, perfume-containing products, etc].
  • Any environmental, physical condition or pathology that can significantly impact on sleep and prevent an approximate 10pm-midnight-6-8am sleep rhythm (e.g., shift work, studying/exams, rotations, insomnia, new parents, nocturia, restless leg syndrome, chronic pain, etc).
  • Any medications that can influence sleep [(e.g., use of beta blockers; anti-histamines; dexamethasone; angiotensin converting enzyme inhibitor (ACEI); nicotine products, alpha blockers]
  • Chemical sensitivities
  • Allergies
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo Pillow
Pillows containing herbs
Active Comparator: Control Pillow
Pillows containing herbs
Experimental: Vata Pillow
Pillows containing herbs
Experimental: Pitta Pillow
Pillows containing herbs
Experimental: Kapha Pillow
Pillows containing herbs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep Function
Time Frame: 2 weeks
Assessments of rest/activity rhythms by wrist actigraphy
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject-reported effects on sleep
Time Frame: 2 weeks
Assessments will be made using the validated sleep questionnaire, Pittsburgh Sleep Quality Index, PSQI
2 weeks
Subject-reported effects on depression
Time Frame: 2 weeks
Assessments will be made using the validated depression questionnaire, Center for Epidemiology Studies-Depression, CES-D
2 weeks
Subject-reported effects on anxiety
Time Frame: 2 weeks
Assessments will be made using the validated anxiety questionnaire, Spielberg State-Trait Anxiety Inventory, STAI
2 weeks
Subject-reported effects on stress
Time Frame: 2 weeks
Assessments will be made using the validated stress questionnaire, Perceived Stress Scale, PSS
2 weeks
Subject-reported effects on quality of life
Time Frame: 2 weeks
Assessments will be made using the validated health-related quality of life questionnaire, quality of life (Health-related Quality of Life, HR-QOL
2 weeks
Ayurvedic assessments of doshas
Time Frame: 2 weeks
Assessment of dosha-specific herbal pillows on dosha balancing
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paula A. Witt-Enderby, Duquesne University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Actual)

July 31, 2025

Study Completion (Actual)

July 31, 2025

Study Registration Dates

First Submitted

January 23, 2024

First Submitted That Met QC Criteria

January 30, 2024

First Posted (Actual)

February 8, 2024

Study Record Updates

Last Update Posted (Actual)

April 17, 2026

Last Update Submitted That Met QC Criteria

April 14, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2023/11/25

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Available upon reasonable request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disturbance

Clinical Trials on Herbal Pillows

Subscribe